Vaccine Market Size, Share, Trends & Forecast

The Vaccine Market is expanding as governments, healthcare organizations, and pharmaceutical companies continue to prioritize immunization and infectious-disease prevention. WiseGuyReports values the global market at USD 50 billion in 2025 and projects it to reach USD 85 billion by 2035, representing a 5.4% CAGR from 2026 to 2035.

The market includes live attenuated, inactivated, subunit, messenger RNA, and vector vaccines. Live attenuated vaccines represent an important segment, while mRNA platforms continue to attract investment because of their flexible development capabilities and potential applications beyond established infectious diseases.

Intramuscular administration remains widely used, while oral, intranasal, and transdermal delivery approaches are receiving increasing attention for their potential convenience and patient acceptance. Research into alternative delivery systems is supporting innovation across vaccine development.

North America remains a leading regional market, supported by advanced healthcare infrastructure and research investment, while Asia-Pacific is expected to experience strong growth as healthcare accessibility and immunization programs expand.

Read More
Lukoon https://lukoon.com